A trial to evaluate therapeutic efficacy after intravesical botulinum toxin A injection for overactive bladder syndrome (OAB) refractory to antimuscarinic therapy
Latest Information Update: 24 Oct 2016
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Overactive bladder
- Focus Therapeutic Use
- 16 Sep 2016 Results (n=89) of analysis of predictors of therapeutic efficacy were presented at the 46th Annual Meeting of the International Continence Society.
- 02 Jun 2016 New trial record
- 10 May 2016 Results presented at the 111th Annual Meeting of the American Urological Association